Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

NVAXNVAX
Showing 8 of 15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in NOVAVAX INC

Yes. Bank of America holds 3,416,235 shares of NVAX (Novavax), worth $32.2M, as of its Q2 2026 13F filing. It reduced the position by 3,220,978 shares (-48.5%) from Q1 2026. Bank of America has held NVAX in every 13F on record since Q4 2022, 15 quarterly filings.

Current Value

$32.2M

Current Shares

3.4M

Total Value Change

+$18.4M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.4M
-48.5%
$32.2M0.0%$9.42
0
2026-Q1
Decreased
6.6M
-19.9%
$54M0.0%$8.14
0
2025-Q4
Increased
8.3M
+167.3%
$55.7M0.0%$6.72
47
2025-Q3
Decreased
3.1M
-1.1%
$26.9M0.0%$8.67
0
2025-Q2
Increased
3.1M
+171.9%
$19.8M0.0%$6.30
46
2025-Q1
Increased
1.2M
+38.8%
$7.4M0.0%$6.41
36
2024-Q4
Decreased
830,756
-24.0%
$6.7M0.0%$8.04
0
2024-Q3
Increased
1.1M
+32.0%
$13.8M0.0%$12.63
36

Other major holders of NVAX: FMR LLC, RA CAPITAL MANAGEMENT, L.P., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used